60 Participants Needed

FiberLocker® System for Rotator Cuff Tears

Recruiting at 1 trial location
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method called the FiberLocker® System to aid in healing rotator cuff tears, which are painful shoulder injuries. Researchers aim to determine if this system enhances healing, function, and safety after surgery. Participants will undergo an MRI at least six months post-surgery to assess shoulder healing. Individuals planning surgery for a significant rotator cuff tear (at least 2 cm) and who have had an MRI within the last year may qualify for this study.

As an unphased trial, this study provides participants the chance to contribute to innovative research that could enhance future treatment options.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have had a corticosteroid injection in the operative shoulder within three months before surgery, you would be excluded from the trial.

What prior data suggests that the FiberLocker® System is safe for rotator cuff repair?

Research shows that safety information for the FiberLocker® System, used in rotator cuff repairs, is collected from surgery through a 12-month follow-up. This system employs a special patch to aid in the repair. Studies have examined the frequency and types of side effects during this period.

MRI scans have confirmed improved healing in previous patients using this system. These scans, conducted at least six months post-surgery, assess the repair's durability. Although specific side effect numbers aren't available, ongoing testing suggests it is reasonably safe so far.

It's important to remember that while the system is designed to be safe, any surgery or medical treatment can have risks. Prospective trial participants should consult their doctor to understand what to expect.12345

Why are researchers excited about this trial?

The FiberLocker® System is unique because it augments traditional rotator cuff repair, potentially enhancing the strength and durability of the repair. While standard treatments for rotator cuff tears typically involve sutures or anchors to reattach the tendon to the bone, the FiberLocker® System adds an extra layer of support. This system could improve healing outcomes and reduce the likelihood of re-tears, offering a promising option for patients with this common shoulder injury. Researchers are excited because it might lead to faster recovery times and better long-term results compared to existing methods.

What evidence suggests that the FiberLocker® System is effective for rotator cuff tears?

Research has shown that the FiberLocker® System, used in rotator cuff repairs, can enhance healing. Studies suggest that this system offers a promising approach for managing difficult rotator cuff tears, which often heal poorly. Early results indicate that the system can reduce the risk of re-tearing and improve tendon healing, as observed in MRI scans at least six months post-surgery. In this trial, all participants will have their rotator cuff tears repaired with augmentation using the FiberLocker® System. This treatment aims to support the repaired tendon, potentially improving movement and increasing patient satisfaction.12356

Are You a Good Fit for This Trial?

This trial is for individuals aged 30-70 planning to have arthroscopic surgery for a full-thickness rotator cuff tear that's at least 2 cm wide. It must be their first repair, and they need an MRI from the last year.

Inclusion Criteria

My tear is 2 cm or larger.
I had an MRI less than a year before my surgery.
I am between 30 and 70 years old.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgical Intervention

Participants undergo arthroscopic rotator cuff repair augmented with the FiberLocker® System

1 day
1 visit (in-person)

Post-operative Monitoring

Participants are monitored for healing and functional outcomes using MRI and various scoring systems

6 months
Multiple visits (in-person and virtual) at 6, 12, and 24 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

24 months
Regular follow-up visits (in-person and virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • FiberLocker® System
Trial Overview The study tests if the FiberLocker® System improves healing and function in rotator cuff repairs. Healing is checked by MRI after at least 6 months, along with other measures like tendon quality and patient-reported outcomes.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Augmentation of Rotator Cuff Repair using the FiberLocker® SystemExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

ZuriMED Technologies Inc.

Lead Sponsor

Citations

Rotator Cuff Tendon Repair With FiberLocker System ...Main secondary outcomes include measures of efficacy and clinical performance evaluated at 6-week, 4.5-month, and 12-month follow-ups including retear rate ...
Rotator Cuff Tendon Repair With FiberLocker System Patch ...The primary outcome of the investigation is to assess the safety after full-thickness arthroscopic rotator cuff repairs augmented with the ...
FiberLocker® System Augmentation of Rotator Cuff RepairsThe primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively. The secondary outcome ...
Patch Augmentation in Arthroscopic Rotator Cuff Surgery ...Managing complex tears is challenging, with failure rates ranging from 20 to 94%. Patch augmentation has emerged as a promising strategy, using ...
FiberLocker® System for Rotator Cuff TearsThe primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively.The secondary outcome ...
FiberLocker® SystemRotator cuff tears affect between 20.4% and 34% of the general population. Despite surgical repair, retear rates remain high—ranging from 24% to 94%.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security